NAMI, RENATO
NAMI, RENATO
70 Tumor associated hypercalcemia
1983-01-01 Gennari, C.; Francini, G.; Nami, R.; Gonnelli, S.; Montagnani, M.
Comparison of valsartan 160 mg with lisinopril 20 mg, given as monotherapy or in combination with a diuretic, for the treatment of hypertension: the Blood Pressure Reduction and Tolerability of Valsartan in Comparison with Lisinopril (PREVAIL) study.
2004-01-01 Malacco, E.; Santonastaso, M.; Varì, N. A.; Gargiulo, A.; Spagnuolo, V.; Bertocchi, F.; Palatini, P.; Prevail Study, Investigators; Nami, R.
Effects of tiapride and sulpiride infusions on plasma levels of beta-endorphin, prolactin and dopamine in patients with neoplastic pain
1983-01-01 Gennari, C.; Nami, R.; Francini, G.; Gonnelli, S.; Bianchini, C.
Evaluation of plasma levels of renin-aldosterone and blood pressure in women over 35 years treated with new oral contraceptives
2001-01-01 DE LEO, V.; LA MARCA, A.; Morgante, G.; Lucani, B.; Nami, R.; Ciotta, L.; Cianci, A.; Petraglia, F.
Hypertension, left ventricular hypertrophy and chronic kidney disease
2011-01-01 Taddei, S.; Nami, R.; Bruno, R. M.; Quatrini, I.; Nuti, R.
Irbesartan in patients with heart failure and preserved ejection fraction
2008-01-01 Massie, B. M.; Carson, P. E.; Mcmurray, J. J.; Komajda, M.; Mckelvie, R.; Zile, M. R.; Anderson, S.; Donovan, M.; Iverson, E.; Staiger, C.; Ptaszynska, A.; I-PRESERVE, Investigators; Nami, R.
Prevalence of type 2 diabetes among patients with hypertension under the care of 30 Italian clinics of hypertension: results of the (Iper)tensione and (dia)bete study
2008-01-01 Lonati, C.; Morganti, A.; Comarella, L.; Mancia, G.; Zanchetti, A.; Iperdia Study, Group; Nami, R.
| Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
|---|---|---|---|---|
| 70 Tumor associated hypercalcemia | 1-gen-1983 | Gennari, C.; Francini, G.; Nami, R.; Gonnelli, S.; Montagnani, M. | - | |
| Comparison of valsartan 160 mg with lisinopril 20 mg, given as monotherapy or in combination with a diuretic, for the treatment of hypertension: the Blood Pressure Reduction and Tolerability of Valsartan in Comparison with Lisinopril (PREVAIL) study. | 1-gen-2004 | Malacco, E.; Santonastaso, M.; Varì, N. A.; Gargiulo, A.; Spagnuolo, V.; Bertocchi, F.; Palatini, P.; Prevail Study, Investigators; Nami, R. | - | |
| Effects of tiapride and sulpiride infusions on plasma levels of beta-endorphin, prolactin and dopamine in patients with neoplastic pain | 1-gen-1983 | Gennari, C.; Nami, R.; Francini, G.; Gonnelli, S.; Bianchini, C. | - | |
| Evaluation of plasma levels of renin-aldosterone and blood pressure in women over 35 years treated with new oral contraceptives | 1-gen-2001 | DE LEO, V.; LA MARCA, A.; Morgante, G.; Lucani, B.; Nami, R.; Ciotta, L.; Cianci, A.; Petraglia, F. | - | |
| Hypertension, left ventricular hypertrophy and chronic kidney disease | 1-gen-2011 | Taddei, S.; Nami, R.; Bruno, R. M.; Quatrini, I.; Nuti, R. | - | |
| Irbesartan in patients with heart failure and preserved ejection fraction | 1-gen-2008 | Massie, B. M.; Carson, P. E.; Mcmurray, J. J.; Komajda, M.; Mckelvie, R.; Zile, M. R.; Anderson, S.; Donovan, M.; Iverson, E.; Staiger, C.; Ptaszynska, A.; I-PRESERVE, Investigators; Nami, R. | - | |
| Prevalence of type 2 diabetes among patients with hypertension under the care of 30 Italian clinics of hypertension: results of the (Iper)tensione and (dia)bete study | 1-gen-2008 | Lonati, C.; Morganti, A.; Comarella, L.; Mancia, G.; Zanchetti, A.; Iperdia Study, Group; Nami, R. | - |